JESSICA P HWANG to Risk Factors
This is a "connection" page, showing publications JESSICA P HWANG has written about Risk Factors.
Connection Strength
0.345
-
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients. J Natl Cancer Inst. 2023 06 08; 115(6):703-711.
Score: 0.066
-
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
Score: 0.053
-
Oncologic Implications of Chronic Hepatitis C Virus Infection. J Oncol Pract. 2019 12; 15(12):629-637.
Score: 0.052
-
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. J Clin Oncol. 2015 Jul 01; 33(19):2212-20.
Score: 0.038
-
Management of patients with hepatitis B who require immunosuppressive therapy. Nat Rev Gastroenterol Hepatol. 2014 Apr; 11(4):209-19.
Score: 0.034
-
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer. 2013 Nov 09; 13:534.
Score: 0.034
-
Hepatitis B virus management to prevent reactivation after chemotherapy: a review. Support Care Cancer. 2012 Nov; 20(11):2999-3008.
Score: 0.031
-
Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation. BMC Cancer. 2009 Feb 04; 9:46.
Score: 0.024
-
Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States. Liver Int. 2019 04; 39(4):748-757.
Score: 0.012